---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-22-000058"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2022-12-01T23:59:59+00:00"
generated_at: "2026-06-21T11:23:02.399537+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Integra to acquire SIA for up to $140M; plans $150M share buyback

## Summary
- Integra buys SIA for $50M at closing plus up to $90M in milestones; deal expected to close by end of 2022.
- SIA 2022E revenue ~$5M; gross margin >75%. Acquisition dilutive ~$0.06 in Year 1, accretive in Year 3.
- ROIC expected to exceed 10% by Year 5 (2027).
- Plans $150M share repurchase starting early 2023 to largely offset Year 1 dilution.
- No FDA-approved surgical matrices for IBBR; Integra's SurgiMend PMA under review, DuraSorb IDE ~70% enrolled.

## SEC filing metadata
- accession: 0000917520-22-000058
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2022-12-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752022000058/0000917520-22-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752022000058/iart-20221130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-22-000058
- JSON: https://secwatch.observer/filing/0000917520-22-000058.json
- Plain text: https://secwatch.observer/filing/0000917520-22-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.